Cytokine Levels Could Predict Immunotherapy Problems

Source: UT Southwestern University

Summary: Researchers at have identified blood-based biomarkers that may help identify those patients at greatest risk of developing autoimmune side effects from the treatment.



From left, Dr. Wakeland, Dr. Gerber, and Dr. Khan are seeking predictors for patients who will develop autoimmune reactions to cancer immunotherapy. Credit: UT Southwestern

More Information: Shaheen Khan et al, “Immune dysregulation in cancer patients developing immune-related adverse events”, British Journal of Cancer (2018). DOI: 10.1038/s41416-018-0155-1 

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *